tirzepatide alzheimer's clinical trial Tirzepatide: a novel therapeutic approach for disease | Metabolic Brain Disease tirzepatide and alzheimer's GLP-1s Alzheimer's:

New WHO guidance on GLP-1 medications With GLP-1 injections becoming increasingly popular and new GLP-1 weight-loss pills on the horizon, its only fitting that the World Health Organization (WHO) has just released new guidance on the meds

Achieving weight loss objectives can result in increased self-esteem, body image, and confidence, all of which have a favourable impact on mental health and social relationships

doi:10.1038/s41591-024-03412-w Hathaway JT, Shah MP, Hathaway DB, et al

Al-Temimi, Anfal Alwan, et al

4, 2025 from MedlinePlus

Route 2: Private MHRA-licensed prescriptions The MHRA licence allows private prescribing at BMI 30 or above, or BMI 27 to 29.9 if you have at least one weight-related comorbidity (a co-occurring health condition that justifies prescribing) 1,2